Scryb Inc. Forum: Community User: Philipp85

Sehe ich mittlerweile auch so. Bin leider fett im Minus:-(

Ich glaube die ganze Firma besteht nur aus Presidents, Vicepresident und viele weitere Presidents, aber ansonsten scheinbar nichts mehr vorzeigbares! Hatte mir eigentlich mehr von der Fa und ihrem Produkt versprochen.

wieder so ein nutzloses news, was keine wirkung hat.

About Raj Kailasanathan Mr. Kailasanathan is a seasoned finance professional with more than 24 years of progressive experience in Asia and North America. Over the last 10 years Raj has served in executive positions for several companies in the MedTech and FinTech sectors. Prior to joining ChroMedX Corp., Raj was the CFO at Kangaroo Group where he led the finance and accounting functions for the company. His insight, relationship management and negotiating skills assisted in the growth of the company, which eventually lead to its sale in April 2017. Prior to Kangaroo Group Raj was Director of Finance and Corporate Treasurer at the TSX listed company Real Matters Inc. Raj is committed and passionate about maximizing long-term shareholder value, entrepreneurism, innovation, growth initiatives, and maintaining a high level of integrity and transparency. The Company also announces that it has granted an aggregate of 300,000 options to purchase common shares of the Company exercisable at today’s closing price per share and expiring on March 20, 2023, to certain directors, officers and consultants of the Company.

ChroMedX Appoints Raj Kailasanathan as Executive Vice President Corporate Finance  March 19, 2018 – ChroMedX Corp. (the “Company”) (CSE: CHX, OTC: CHXIF, Frankfurt: EIY2), developer of the HemoPalm Handheld Blood Analyzer Platform, is pleased to announce the appointment of Raj Kailasanathan as ChroMedX Corp. Executive Vice President, Corporate Finance. Mr. Kailasanathan joins ChroMedX as a seasoned finance executive with over 20 years experience in the private and public industry in Asia and North America. Prior to joining ChroMedX Corp., Raj was CFO at the innovative Toronto-based Medical Devices Product Development and Contract Manufacturing organization, Kangaroo Group, Where he led finance and accounting functions and was instrumental in preparing the company for sale in April 2017 to Starfish Medical. “It is a great pleasure to welcome Raj to ChroMedX as part of our expanded executive team. He will play a crucial role in the management and strategy of financial operations as ChroMedX grows.” said Lahav Gil, CEO & Director, ChroMedX Corp. “ Prior to joining Kangaroo, Raj acted as Director of Finance and Corporate Treasurer at TSX listed company Real Matters Inc. “I am thrilled to have the opportunity to be part of the team and to contribute to the growth and evolution of ChroMedX, said Raj Kailansanathan, EVP Corporate Finance, ChroMedX Corp. “This is an exciting time for all involved and I’d like to thank Lahav and the board of directors for this appointment.”

Nix ist los....schade

Was ist hier nur los? Man man...

Alles gut!!! Mir geht es nur aufn Sack das man sich hier vollpisst und wenn es rauf geht wieder auf die Schulter klopft. Das Ding muss doch mal kommen. Hallo Polli!!!

@blackfoot: sowas Ähnliches wollte ich auch schreiben, nur mit Leverkusen und Bayer....

Hättet ihr Freunde, bräuchtet ihr nicht diesen Chat.

hab ein freund in Bafin, und die haben Recht.

Hab ein freund in Amsterdam, cannabis is scheiße.

Und wer bist du?

Habe ein freund in kanada Chromedx sind gauner

Ruhig bleiben bei dem Kurs ist gut! Hoffe nur das Anfang April was kommt.

Jungs bleibt ruhig, es gibt doch schon genug Hater im Chat.